XBiotech Inc.
XBIT
$2.67
-$0.28-9.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.51M | -5.02M | -13.01M | -10.00M | -4.64M |
| Total Depreciation and Amortization | 439.00K | 439.00K | 435.00K | 432.00K | 434.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.73M | -342.00K | 933.00K | 1.96M | -559.00K |
| Change in Net Operating Assets | -1.20M | -927.00K | 262.00K | 405.00K | 1.33M |
| Cash from Operations | -6.54M | -5.85M | -11.38M | -7.20M | -3.43M |
| Capital Expenditure | -84.00K | -338.00K | -627.00K | -255.00K | -115.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -84.00K | -338.00K | -627.00K | -255.00K | -115.00K |
| Total Debt Issued | 250.00K | 0.00 | 0.00 | 10.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.00K | 64.00K | 48.00K | 55.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 283.00K | 64.00K | 48.00K | 10.06M | 0.00 |
| Foreign Exchange rate Adjustments | -4.10M | 707.00K | -554.00K | -1.58M | 1.38M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.44M | -5.41M | -12.51M | 1.02M | -2.17M |
